Adora Ndu - 29 May 2025 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
29 May 2025
Transactions value $
$0
Form type
4
Filing time
02 Jun 2025, 18:05:12 UTC
Previous filing
15 Oct 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ndu Adora Director C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO /s/ Jennifer J. Rhodes, Attorney-in-Fact 02 Jun 2025 0001865210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +9.39K +60.9% 24.8K 29 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -9.39K -100% $0.00 0 29 May 2025 Common Stock 9.39K Direct F1, F2
transaction ACAD Director Stock Options (Right to Buy) Award $0 +13.8K $0.00 13.8K 29 May 2025 Common Stock 13.8K $22.29 Direct F3
transaction ACAD Restricted Stock Units Award $0 +8.11K $0.00 8.11K 29 May 2025 Common Stock 8.11K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2 The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held.
F3 The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.
F4 The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.